Trial intelligence / Profile preview

High cut point procalcitonin-guided antibiotic therapy in surgical critically ill patients

TCTR20170210001Phase 4Recruiting

Sponsor
Faculty of medicine
Start
Oct 2016
Countries
1
01

Overview

Phase 4, randomised, open-label trial in bacterial disease and sepsis (2 arms), sponsored by Faculty of medicine. Primary endpoint: Primary outcome (unspecified). Started Oct 2016; status: recruiting.

02

Conditions

bacterial diseasesepsis

Beyond the preview

Go deeper on TCTR20170210001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170210001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call